Vancouver, Canada

Amina Zoubeidi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Amina Zoubeidi: Innovator in Cancer Treatment

Introduction

Amina Zoubeidi is a prominent inventor based in Vancouver, Canada, known for her significant contributions to cancer treatment research. With a total of four patents to her name, she has made strides in developing innovative therapies for neoplastic disorders.

Latest Patents

Among her latest patents is a groundbreaking method for treating prostate cancer using androgen-targeted therapies. This patent describes methods and compositions aimed at treating prostate cancer, particularly in cases that are castration-resistant and resistant to androgen receptor antagonists. The treatment methods may involve administering a CYP17-lyase inhibitor of a specific formula. Another notable patent focuses on combination therapy for cancer, utilizing HSP27 inhibitors alongside EGFR tyrosine kinase inhibitors or anti-folates. This innovative approach aims to enhance the effectiveness of cancer treatments.

Career Highlights

Amina has worked with notable organizations such as Tokai Pharmaceuticals, Inc. and the University of Washington. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer research.

Collaborations

Amina has collaborated with esteemed colleagues, including Vincent C. O. Njar and Karen Ferrante. These partnerships have played a crucial role in her research and development efforts.

Conclusion

Amina Zoubeidi's work exemplifies the impact of innovative research in the field of cancer treatment. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…